Trial Helps Unravel Migraine-Depression Knot

(MedPage Today) -- Fremanezumab (Ajovy) reduced depression symptoms and monthly migraine attacks in people with episodic or chronic migraine and major depressive disorder, the phase IV UNITE trial showed.
The mean change from baseline in monthly...